Target intelligence / Profile preview

RC3H1 divergent transcript (RC3H1-DT)

Target
RC3H1-DT
Molecular classification
Other (Long non-coding RNA; lncRNA)
01

Overview

RC3H1 divergent transcript (RC3H1-DT), also known as LINC02776, is a long intergenic non-protein coding RNA identified in the human genome. It is formally annotated in gene databases but presently has no described biological functions, disease associations, or established therapeutic relevance[1]. As an lncRNA, it may be involved in regulatory genomic processes, though no specific roles have been published. It should not be confused with protein-coding Rc3h1 (Roquin-1), which regulates immune homeostasis[2]. Key distinctions: - RC3H1-DT/LINC02776 is a lncRNA and not a protein[1]. - Rc3h1 (Roquin-1) is a protein (distinct from the transcript), involved in immune regulation and RNA binding, but this is a separate entity[2]. RC3H1 divergent transcript is therefore not considered a therapeutic target, with no current evidence for functional characterization, disease involvement, or drug interactions.

Other names
LINC02776long intergenic non-protein coding RNA 2776RC3H1 divergent transcript

Beyond the preview

Go deeper on RC3H1 divergent transcript (RC3H1-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RC3H1 divergent transcript (RC3H1-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call